Literature DB >> 23196277

Chronic obstructive pulmonary disease and risk of lung cancer: the importance of smoking and timing of diagnosis.

Helen A Powell1, Barbara Iyen-Omofoman, David R Baldwin, Richard B Hubbard, Laila J Tata.   

Abstract

INTRODUCTION: The majority of cases of both lung cancer and chronic obstructive pulmonary disease (COPD) are attributable to cigarette smoking, but whether COPD is an independent risk factor for lung cancer remains unclear.
METHODS: We used The Health Improvement Network, a U.K. general practice database, to identify incident cases of lung cancer and controls matched on age, sex, and practice. Using conditional logistic regression, we assessed the effects of timing of first diagnoses of COPD, pneumonia, and asthma on the odds of lung cancer, adjusting for smoking habit.
RESULTS: Of 11,888 incident cases of lung cancer, 23% had a prior diagnosis of COPD compared with only 6% of the 37,605 controls. The odds of lung cancer in patients who had COPD diagnosed within 6 months of their cancer diagnosis were 11-fold those of patients without COPD (odds ratio 11.47, 95% confidence interval 9.38-14.02). However, when restricted to earlier COPD diagnoses, with adjustment for smoking, the effect markedly diminished (for COPD diagnoses >10 years before lung cancer diagnosis, odds ratio: 2.18, 95% confidence interval: 1.87-2.54). The pattern was similar for pneumonia. The effect of COPD on lung cancer remained after excluding patients who had a codiagnosis of asthma.
CONCLUSION: A diagnosis of COPD is strongly associated with a diagnosis of lung cancer, however, this association is largely explained by smoking habit, strongly dependent on the timing of COPD diagnosis, and not specific to COPD. It seems unlikely, therefore, that COPD is an independent risk factor for lung cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23196277     DOI: 10.1097/JTO.0b013e318274a7dc

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  30 in total

1.  Cigarette smoke activates the proto-oncogene c-src to promote airway inflammation and lung tissue destruction.

Authors:  Patrick Geraghty; Andrew Hardigan; Robert F Foronjy
Journal:  Am J Respir Cell Mol Biol       Date:  2014-03       Impact factor: 6.914

2.  Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.

Authors:  Jens Köhler; Martin Schuler; Thomas Christoph Gauler; Stefanie Nöpel-Dünnebacke; Maike Ahrens; Andreas-Claudius Hoffmann; Stefan Kasper; Felix Nensa; Benedikt Gomez; Maria Hahnemann; Frank Breitenbuecher; Danjouma Cheufou; Filiz Özkan; Kaid Darwiche; Mathias Hoiczyk; Henning Reis; Stefan Welter; Wilfried Ernst Erich Eberhardt; Martin Eisenacher; Helmut Teschler; Georgios Stamatis; Wolff Schmiegel; Stephan Albrecht Hahn; Alexander Baraniskin
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-19       Impact factor: 4.553

3.  Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis.

Authors:  Amirhossein Fathinavid; Mohadeseh Zarei Ghobadi; Ali Najafi; Ali Masoudi-Nejad
Journal:  BMC Genom Data       Date:  2021-10-12

Review 4.  Molecular Radiobiology in Non-Small Cell Lung Cancer: Prognostic and Predictive Response Factors.

Authors:  Javier Peinado-Serrano; Amancio Carnero
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

Review 5.  Lung cancer screening in patients with chronic obstructive pulmonary disease.

Authors:  Jessica Gonzalez; Marta Marín; Pablo Sánchez-Salcedo; Javier J Zulueta
Journal:  Ann Transl Med       Date:  2016-04

6.  The impact of recombinant parathyroid hormone on malignancies and mortality: 7 years of experience based on nationwide Danish registers.

Authors:  U C Bang; L Hyldstrup; J E B Jensen
Journal:  Osteoporos Int       Date:  2013-08-14       Impact factor: 4.507

7.  Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.

Authors:  Melissa J McDonnell; Stefano Aliberti; Pieter C Goeminne; Marcos I Restrepo; Simon Finch; Alberto Pesci; Lieven J Dupont; Thomas C Fardon; Robert Wilson; Michael R Loebinger; Dusan Skrbic; Dusanka Obradovic; Anthony De Soyza; Chris Ward; John G Laffey; Robert M Rutherford; James D Chalmers
Journal:  Lancet Respir Med       Date:  2016-11-16       Impact factor: 30.700

8.  Proliferation Genes Repressed by TGF-β Are Downstream of Slug/Snail2 in Normal Bronchial Epithelial Progenitors and Are Deregulated in COPD.

Authors:  Chamseddine Ben Brahim; Charlotte Courageux; Ariane Jolly; Bérengère Ouine; Aurélie Cartier; Pierre de la Grange; Leanne de Koning; Pascale Leroy
Journal:  Stem Cell Rev Rep       Date:  2021-01-26       Impact factor: 5.739

9.  Does chronic obstructive pulmonary disease with or without type 2 diabetes mellitus influence the risk of lung cancer? Result from a population-based cohort study.

Authors:  Te-Chun Shen; Wei-Sheng Chung; Cheng-Li Lin; Chang-Ching Wei; Chia-Hung Chen; Hung-Jen Chen; Chih-Yen Tu; Te-Chun Hsia; Chuen-Ming Shih; Wu-Huei Hsu; Chi-Jung Chung
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

10.  Surveillance of chronic obstructive pulmonary disease in high-risk individuals by using regional lung cancer mass screening.

Authors:  Yasuo Sekine; Ryoko Yanagibori; Kiminori Suzuki; Sonomi Sugiyama; Haruko Yamaji; Michiko Ishibashi; Takehiko Fujisawa
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.